RENEY FONTENOT: Open Payments
NPI 1295572774 · JENNINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 35 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $733 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $146 |
| ABBVIE INC. | 13 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $121 |
| Vanda Pharmaceuticals Inc. | 5 | $93 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Indivior Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: COBENFY, VRAYLAR, CAPLYTA, FANAPT, Auvelity, UZEDY, SUBLOCADE, HETLIOZ.
Industry payments across LA — which companies pay providers there.
